Tumour‐mediated disruption of dendritic cell function: Inhibiting the MEK1/2‐p44/42 axis restores IL‐12 production and Th1‐generationAndrew M. Jackson(University of Nottingham), Poulam M. Patel(University of Nottingham)International Journal of CancerMay 13, 200810.1002/ijc.23530Cited by 38SaveCiteExport RISWatch citationsRelated PapersResistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma|Cells|2020|65Novel function for the p38‐MK2 signaling pathway in circulating CD1c+ (BDCA‐1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL‐12 whilst suppressing IL‐10|International Journal of Cancer|2013|16